The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy

被引：0
|
作者：
Liu, W. [1 ]
Xi, Z. W. [1 ]
Zhou, Y. J. [1 ]
机构：
[1] Beijing Anzhen Hosp, Caridiol, Beijing, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4010
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [1] The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy
    Liu, W.
    Xi, Z. W.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 613 - 613
  • [2] Effect of Gender on Clinical Outcomes in Patients Receiving CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
    Gustafson, Chelsea
    Gower, Megan N.
    Williams, Alexis K.
    Pauley, Eric
    Weck, Karen E.
    Lee, Craig R.
    Stouffer, George A.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (05): : 554 - 556
  • [3] Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping
    Coons, James C. C.
    Stevenson, James M. M.
    Patel, Ami
    Smith, A. J. Conrad
    Prebehalla, Linda
    Empey, Philip E. E.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [4] The impact of CYP2C19 gene polymorphism on the antiplatelet effect of clopidogrel and ticlopidine; the efficacy of ticlopidine on the non-responders of clopidogrel with CYP2C19 gene polymorphism
    Ishiguro, H.
    Asai, T.
    Umemoto, N.
    Sumida, A.
    Shimizu, K.
    Murohara, T.
    Maeda, A.
    Ando, H.
    Fujimura, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 968 - 968
  • [5] Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
    Al-Rubaish, Abdullah M.
    Al-Muhanna, Fahad A.
    Alshehri, Abdullah M.
    Al-Mansori, Mohammed A.
    Alali, Rudaynah A.
    Khalil, Rania M.
    Al Faraidy, Khalid A.
    Cyrus, Cyril
    Sulieman, Mohammed M.
    Vatte, Chittibabu
    Claassens, Daniel M. F.
    ten Berg, Jurrien M.
    Asselbergs, Folkert W.
    Al-Ali, Amein K.
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [6] Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
    Abdullah M. Al-Rubaish
    Fahad A. Al-Muhanna
    Abdullah M. Alshehri
    Mohammed A. Al-Mansori
    Rudaynah A. Alali
    Rania M. Khalil
    Khalid A. Al Faraidy
    Cyril Cyrus
    Mohammed M. Sulieman
    Chittibabu Vatte
    Daniel M. F. Claassens
    Jurriën M. ten Berg
    Folkert W. Asselbergs
    Amein K. Al-Ali
    BMC Cardiovascular Disorders, 20
  • [7] CYP2C19 Genotype-Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure
    Tunehag, Kayla R.
    Pearce, Ashton F.
    Fox, Layna P.
    Stouffer, George A.
    Solander, Sten
    Lee, Craig R.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):
  • [8] Precision Antiplatelet Therapy for CYP2C19 Genotype Variants for Achieving Better Clinical Outcomes
    Cha, Jung-Joon
    Lim, Do-Sun
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (13) : 1500 - 1501
  • [9] CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients
    Yang Jie
    Zhao Hong-Dong
    Tan Jie
    Ding Yun-Long
    Zou Jian-Jun
    PHARMAZIE, 2013, 68 (03): : 183 - 186
  • [10] CYP2C19 polymorphism in Korean patients on warfarin therapy
    Lee, Sukhyang
    Hwang, Hyun Jin
    Kim, Jae-Moon
    Chung, Chin-Sang
    Kim, Jeong Hee
    ARCHIVES OF PHARMACAL RESEARCH, 2007, 30 (03) : 344 - 349
12345